Current Methods for Analysing Mesenchymal Stem Cell-Derived Extracellular Vesicles

Ana Kolenc,Elvira Maličev

DOI: https://doi.org/10.3390/ijms25063439

IF: 5.6

2024-03-20

International Journal of Molecular Sciences

Abstract:The use of extracellular vesicles (EVs) generated by mesenchymal stem cells (MSCs) holds great promise as a novel therapeutic approach. Although their immunomodulatory and regeneration potential has been reported to be similar to that of MSCs, the use of MSC-derived EVs in clinical settings will require several problems to be resolved. It is necessary to develop a standardised and widely accepted isolation technology and to improve methods such as the quantification and characterisation of MSC-derived EVs. In this way, EV studies can be compared, the acquired knowledge can be safely transferred to clinical platforms and the clinical results can be evaluated appropriately. There are many procedures for the collection and analysis of vesicles derived from different cells; however, this review provides an overview of methods for the determination of the total protein amount, specific proteins, particle number, non-protein markers like lipids and RNA, microscopy and other methods focusing on MSC-derived EVs.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the analysis methods of extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs). Although these EVs show similar potential to MSCs in immunomodulation and tissue regeneration, several key issues need to be resolved before they can be applied in the clinical setting. These issues include:

1. **Standardized isolation techniques**: A standardized and widely - accepted EVs isolation technique needs to be developed to ensure that the results are comparable between different studies.
2. **Improvement of quantification and characterization methods**: Existing methods, such as those for quantifying and characterizing MSCs - derived EVs, need to be further improved in order to more accurately assess the quantity, size, protein content, non - protein markers (such as lipids and RNA), etc. of EVs.
3. **Enhancing the reproducibility and consistency of research**: By improving the analysis methods, ensure the consistency and reproducibility of research results, so that research achievements can be safely transformed into clinical applications and clinical results can be appropriately evaluated.
4. **Solving the problem of large - scale production**: Currently, there is a lack of a method that can produce EVs with customized therapeutic properties on a large scale, which is a major obstacle to clinical applications.

In summary, this paper aims to provide a comprehensive review of various current methods for analyzing MSCs - derived EVs, including total protein quantification, specific protein detection, particle number and size determination, non - protein marker detection, microscopy, etc., in order to provide guidance and support for future research and clinical applications.